Promising survival and concomitant radiation plus temozolomide followed by adjuvant temozolomide

被引：4
|
作者：
Beauchesne, P [1 ]
机构：
[1] INSERM, U453, F-69008 Lyon, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 14期
关键词：
D O I：
10.1200/JCO.2002.20.14.3180
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3180 / 3181
页数：2
相关论文
共 50 条
  • [21] Radiotherapy plus concomitant and adjuvant temozolomide for leptomeningeal pilomyxoid astrocytoma: a case study
    Roelien H. Enting
    Winette T. A. van der Graaf
    Johan M. Kros
    Mart Heesters
    Jan Metzemaekers
    Wilfred den Dunnen
    [J]. Journal of Neuro-Oncology, 2006, 80 : 107 - 108
  • [22] A phase II trial of radiation plus temozolomide followed by adjuvant temozolomide and poly-ICLC in patients with newly diagnosed glioblastoma multiforme (NABTT #0501)
    Rosenfeld, M. R.
    Chamberlain, M. C.
    Grossman, S. A.
    Peereboom, D. M.
    Lesser, G. J.
    Batchelor, T. T.
    Desideri, S.
    Salazar, A. M.
    Ye, X.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [23] Trotabresib (CC-90010) in combination with adjuvant temozolomide or concomitant temozolomide plus radiotherapy in patients with newly diagnosed glioblastoma
    Vieito, Maria
    Simonelli, Matteo
    de Vos, Filip
    Moreno, Victor
    Geurts, Marjolein
    Lorenzi, Elena
    Macchini, Marina
    van den Bent, Martin J.
    Del Conte, Gianluca
    de Jonge, Maja
    Martin-Soberon, Maria Cruz
    Amoroso, Barbara
    Sanchez-Perez, Tania
    Zuraek, Marlene
    Hanna, Bishoy
    Aronchik, Ida
    Filvaroff, Ellen
    Chang, Henry
    Mendez, Cristina
    Arias Parro, Marina
    Wei, Xin
    Nikolova, Zariana
    Sepulveda, Juan Manuel
    [J]. NEURO-ONCOLOGY ADVANCES, 2022, 4 (01)
  • [24] RADIOTHERAPY AND ADJUVANT TEMOZOLOMIDE COMPARED WITH RADIOTHERAPY AND CONCOMITANT PLUS ADJUVANT TEMOZOLOMIDE IN SURGICALLY TREATED PATIENTS WITH GLIOBLASTOMA MULTIFORME: A RETROSPECTIVE SINGLE INSTITUTION STUDY
    Goeppert, M.
    Felsberg, J.
    Stummer, W.
    Reifenberger, G.
    Steiger, H.
    Sabel, M.
    [J]. NEURO-ONCOLOGY, 2008, 10 (06) : 1124 - 1124
  • [25] EARLY INITIATION OF RADIOTHERAPY PLUS CONCOMITANT AND ADJUVANT TEMOZOLOMIDE (TMZ) AND OVERALL SURVIVAL (OS) IN GLIOBLASTOMA (GBM) PATIENTS
    Roessler, K.
    Muxel, M.
    Zachenhofer, I.
    Maier, R.
    DeVries, A.
    [J]. NEURO-ONCOLOGY, 2010, 12 : 48 - 48
  • [26] Glioblastomas treated by radiotherapy with concomitant and adjuvant temozolomide
    Malinova, B.
    Lohynska, R.
    Pajdlhauser, R.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S295 - S295
  • [27] A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma
    Shenouda, George
    Souhami, Luis
    Petrecca, Kevin
    Owen, Scott
    Panet-Raymond, Valerie
    Guiot, Marie-Christine
    Corredor, Andrea Gomez
    Abdulkarim, Bassam
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (03): : 487 - 494
  • [28] EXTENDED ADJUVANT TEMOZOLOMIDE AFTER CONCOMITANT RADIO-CHEMOTHERAPY WITH TEMOZOLOMIDE IN MALIGNANT GLIOMAS
    Anghel, R.
    Gales, L.
    Isacu, I.
    Tarlea, A.
    Bacinschi, X.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 335 - 335
  • [29] A Phase 2 Study of Neo-adjuvant Metformin and Temozolomide followed by Hypofractionated Accelerated RadioTherapy (HART) with Concomitant and Adjuvant Metformin and Temozolomide (TMZ) in Patients with Glioblastoma
    Shenouda, G.
    Souhami, L.
    Petrecca, K.
    Panet-Raymond, V.
    Owen, S.
    Diaz, R. J.
    Hall, J.
    Guiot, M. C.
    Carvalho, T.
    Abdulkarim, B. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S21 - S21
  • [30] Radiotherapy plus concomitant temozolomide in primary gliosarcoma
    Adeberg, Sebastian
    Bernhardt, Denise
    Ben Harrabi, Semi
    Diehl, Christian
    Koelsche, Christian
    Rieken, Stefan
    Unterberg, Andreas
    von Deimling, Andreas
    Debus, Juergen
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2016, 128 (02) : 341 - 348
12345